April 18, 2023
Bilge Ozaydin is the Director of the Strain Discovery and Development group at Pivot Bio. The QB3-Berkeley Professionals in Residence program will be joined by Ozaydin on Friday, May 5th.…
March 17, 2023
Andy Hsieh, PhD, is a biotechnology analyst at William Blair. Hsieh is joining the QB3-Berkeley Professionals in Residence (PIR) program on Friday, March 24, 2023. UC Berkeley and Lawrence Berkeley…
January 11, 2023
Miki Yamamoto, PhD, is the vice president and head of regulatory affairs at Arrivent Biopharma. Yamamoto is joining the QB3-Berkeley Professionals in Residence (PIR) program on February 9th 2023. UC…
November 15, 2022
Katja Brose, PhD, is a science program officer at the Chan Zuckerberg Initiative (CZI). Brose is joining the QB3-Berkeley Professionals in Residence (PIR) program on January 26th, 2023. UC Berkeley…
April 26, 2022
Seth Lieblich, PhD, is a principal at venture capital firm 8VC focusing on life sciences technologies. He joins the QB3-Berkeley Professional in Residence program on May 6th. Lieblich spoke to…
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In…
February 23, 2022
While graduate students in the College of Chemistry have long been leading DEI efforts and initiatives to improve the unit’s climate, a new program provides more support and compensation for…
January 24, 2022
Christopher Hann-Soden discusses the breadth of services offered at UC Berkeley’s QB3 Genomics Core Facility. The QB3 Genomics core research facility is an umbrella term for three separate UC Berkeley…